Robin Marty has a post up at Care 2 about Pamela Fink, who believes she was fired for testing positive for a gene that is associated with a high risk of breast cancer:
Fink claims the dramatic shift in her standing at MXenergy spurs from her revelation that she had tested positive for the BRCA2 gene, which can increase one’s risk for breast cancer. Fink said she told her employers about her genetic testing in August — shortly after her positive performance review and about two months before she had a double mastectomy as a preventative measure. When she returned from medical leave, that’s when her responsibilities began slipping away and the assessment of her work went from glowing to negative.
Read the rest here.